Surveillance

Canadian Paediatric Surveillance Program
Neonatal Herpes Simplex Virus Infection

Duration

Phase I through the CPSP – October 2000 to September 2003

Phase II through Health Canada – Follow-up of three successive cohorts of HSV infected infants for a period of three years each, October 2001 to September 2006.

Principal investigator

Dr. Tom Wong, Division of Community Acquired Infections, Centre for Infectious Disease Prevention and Control, Health Canada,7th Floor, Jeanne Mance Bldg., Room 701A, Tunney's Pasture AL:1907A4, Ottawa ON K1A 0K9; tel: 613-957-1080; fax: 613-957-0381; e-mail: Tom_Wong@hc-sc.gc.ca

Co-investigators

Dr. Joanne Embree, University of Manitoba
Dr. I.D. Rusen, Health Surveillance and Epidemiology Division, Health Canada
Dr. Marc Steben, Régie régionale de la santé et des services sociaux, Montréal
Sandra Burton, Division of Community Acquired Infectionsl, Health Canada

Study Results

Results can be found in the CPSP 2003 Results (pdf format).

Study publications/presentations

CPSP resource

• Neonatal Herpes Simplex Virus Infection

CPSP highlights

• CPSP 2002 Results: What have we learned? 
  
  
• Neonatal herpes simplex virus infection: A devastating newborn pathogen.

Publications

• Neonatal herpes simplex virus infections in Canada. Kropp RY, Wong T, Burton S, Embree J, Steben M. International Journal of STD & AIDS: Clinical Practice in Sexual Health 2004;15(S1):2
  
  
• The Canadian Paediatric Surveillance Program: Beyond collecting numbers

Presentations 

• Public health impact of the Canadian Paediatric Surveillance Program (CPSP)
  
  
• Neonatal herpes simplex virus infections in Canada. Kropp RY, Wong T, Burton S, Embree J, Steben M. Presented at the BASHH/ASTDA Spring Meeting, Bath, UK, May 2004
  
  
• Public health implications of the Candadian Paediatric Surveillance Program.  
  
  
• Neonatal herpes simplex virus infections in Canada. 
  
  
• The Canadian Paediatric Surveillance Program (CPSP): An epidemiological tool in action